Proximagen acts as the research and early development unit of Upsher Smith Laboratories and is focused on the discovery and development of novel therapeutics for diseases of the central nervous system (CNS)

Breaking News: "ROCHE AND UPSHER-SMITH ANNOUNCE LICENSE AGREEMENT TO DEVELOP NOVEL VAP-1 INHIBITOR"